Package Leaflet: Information for the User
Geloprofen Pediatric 40 mg/ml Oral Suspension
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist exactly.
Package Leaflet Contents
Geloprofen Pediatric contains ibuprofen as the active ingredient and belongs to a group of medications called non-steroidal anti-inflammatory drugs (NSAIDs).
This medication is used in children from 3 months, adolescents, and adults for the symptomatic relief of occasional mild or moderate pain, as well as in febrile states.
Do not take Geloprofen pediatric
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take this medicine:
Infections
Geloprofen pediatric may hide the signs of an infection, such as fever and pain. Consequently, Geloprofen pediatric may delay the appropriate treatment of the infection, which can increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Skin reactions
Severe skin reactions have been reported in association with ibuprofen treatment. Stop taking ibuprofen and go to the doctor immediately if you present any skin rash, lesions on the mucous membranes, blisters, or other signs of allergy, as these can be the first signs of a very severe skin reaction. See section 4.
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Interrupt treatment with Geloprofen pediatric and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
It is important that you use the smallest dose that relieves/controls the pain and do not take this medicine for longer than necessary to control your symptoms.
Cardiovascular precautions
Anti-inflammatory/analgesic medicines like ibuprofen may be associated with a small increase in the risk of suffering a heart attack or stroke, especially when used in high doses and in prolonged treatments. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking ibuprofen if:
Similarly, this type of medicine can produce fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
Respiratory disorders
Ibuprofen should be used with caution when administered to patients who have or have a history of bronchial asthma, chronic rhinitis, or allergic diseases, as ibuprofen has been reported to cause bronchospasm, urticaria, or angioedema in such patients.
Children and adolescents
There is a risk of kidney damage in dehydrated children and adolescents.
In case of administration of this medicine in adults
Elderly patients
Elderly patients have a higher risk of adverse events when taking NSAIDs, especially of a stomach and intestinal type. See section 4 "Possible side effects" for more information.
Patient with a history of gastrointestinal toxicity, especially elderly patients, should report any unusual abdominal symptoms (especially gastrointestinal bleeding), especially in the early stages of treatment.
Interference with analytical tests
If you are going to undergo any diagnostic test (including blood tests, urine tests, skin tests that use allergens, etc.), inform your doctor that you are taking this medicine, as it may alter the results.
Other medicines and Geloprofen pediatric
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine, even those purchased without a prescription.
Ibuprofen may affect or be affected by other medicines. For example:
Other medicines may also affect or be affected by treatment with ibuprofen. Therefore, you should always consult your doctor or pharmacist before using ibuprofen with other medicines.
Taking Geloprofen pediatric with food, drinks, and alcohol
It is recommended to take this medicine with milk or with food, or immediately after eating, to reduce the possibility of stomach upset.
It is not recommended to drink alcohol during treatment, as it increases the risk of gastrointestinal or central nervous system side effects.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Ibuprofen should not be taken during pregnancy, especially during the third trimester (see section precautions during pregnancy and in women of childbearing age).
Because the administration of ibuprofen-like medicines has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy unless it is strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
Do not take Geloprofen pediatric if you are in the last 3 months of pregnancy, as it could harm the fetus or cause problems during delivery. It can cause kidney and heart problems in your fetus. It can affect your and your baby's tendency to bleed and delay or prolong delivery more than expected. You should not take Geloprofen pediatric during the first 6 months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you will take the minimum dose for the shortest time possible. From the 20th week of pregnancy, Geloprofen pediatric may cause kidney problems in your fetus if taken for more than a few days, which can cause low levels of the fluid that surrounds the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional checks.
Breastfeeding
Although only small amounts of the medicine pass into breast milk, it is recommended not to take ibuprofen for prolonged periods during breastfeeding.
Female fertility
For patients of childbearing age, it should be taken into account that ibuprofen-like medicines have been associated with a decrease in fertility. This effect is reversible upon discontinuation of the medicine.
Driving and using machines
If you experience dizziness, vertigo, vision changes, or other symptoms while taking this medicine, you should not drive or use hazardous machinery.
If you only take one dose of the medicine or take it for a short period, it is not necessary to take special precautions.
Geloprofen pediatric contains maltitol liquid (E-965), sodium, sodium benzoate (E-211), and benzyl alcohol (in the aroma).
This medicine contains maltitol liquid. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Patients on low-sodium diets should note that this medicine contains 5.79 mg (0.25 mmol) of sodium per milliliter.
This medicine contains 1 mg of sodium benzoate per milliliter.
This medicine contains 0.0002 mg/ml of benzyl alcohol (in the aroma). Benzyl alcohol may cause allergic reactions.
Benzyl alcohol has been linked to the risk of serious side effects, including respiratory problems ("gasping syndrome") in children.
Do not administer this medicine to your newborn (up to 4 weeks of age) unless your doctor has recommended it.
This medicine should not be used for more than one week in children under 3 years of age unless indicated by your doctor or pharmacist.
Consult your doctor or pharmacist if you are pregnant or breastfeeding. This is because large amounts of benzyl alcohol can accumulate in your body and cause side effects (metabolic acidosis).
Consult your doctor or pharmacist if you have liver or kidney disease. This is because large amounts of benzyl alcohol can accumulate in the body and cause side effects (metabolic acidosis).
Follow the administration instructions for this medication exactly as contained in this prospectus or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
For occasional use only and for a limited period.
It is essential that you use the smallest dose that relieves-controls the pain and should not take this medication for longer than necessary to control your symptoms.
The lowest effective dose should be used for the shortest duration necessary to relieve symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Use in Children
The recommended dose of ibuprofen depends on the child's age and weight. As a general rule, the recommended daily dose is 20 to 30 mg of ibuprofen per kg of the child's weight, divided into three or four individual doses. It is recommended not to exceed the maximum daily dose of 40 mg of ibuprofen per kg of weight. The interval between doses will depend on the evolution of symptoms, but will never be less than 4 hours.
Use in children under 3 months or weighing less than 5 kg is not recommended.
The recommended dose for pain and fever is:
IBUPROFEN DOSAGE IN CHILDREN | |||
Age/Weight | Frequency | Dosage | Maximum Daily Dose |
3 to 6 months* 5 – 7.6 kg approx | 3 times a day | 50 mg (1.25 ml)/dose | 150 mg (3.75 ml) |
6 – 12 months* 7.7 - 9 kg approx | 3 to 4 times a day | 50 mg (1.25 ml)/dose | 150–200 mg (3.75-5ml) |
1 – 3 years* 10 – 15 kg approx | 3 to 4 times a day | 100 mg (2.5 ml)/dose | 300-400 mg (7.5-10 ml) |
4 – 6 years 16 – 20 kg approx. | 3 to 4 times a day | 150 mg (3.75 ml)/dose | 450-600 mg (11.25-15 ml) |
7 – 9 years 21 – 29 kg approx. | 3 to 4 times a day | 200 mg (5 ml)/dose | 600–800 mg (15-20 ml) |
10 – 12 years 30 – 40 kg approx. | 3 to 4 times a day | 300 mg (7.5 ml)/dose | 900-1200 mg (22.5-30 ml) |
Adults and adolescents (over 12 years)
A dose of 5-10 ml (equivalent to 200-400 mg of ibuprofen) should be taken every 4 or 6 hours, if necessary, without exceeding 1200 mg of ibuprofen in a 24-hour period.
Due to the amount of ibuprofen contained in this medication, the use of other more suitable presentations for the treatment of these patients is recommended.
Patient with kidney and/or liver disease
If you have kidney and/or liver disease, you should reduce the dose and consult your doctor.
Elderly patients
If you are over 65 years old, the amount to be taken should be established by your doctor, as it may be necessary to reduce the usual dose.
Elderly people are often more prone to its effects, so sometimes the dose needs to be reduced. Consult your doctor.
For occasional use and for a limited period.
Consult your doctor if during the treatment period the symptoms persist or worsen.
Children from 3 to 5 months, consult a doctor if symptoms worsen or if after 24 hours they persist.
In children from 6 months of age and adolescents up to 18 years, consult a doctor if it is necessary to administer the medication for more than 3 days or if symptoms worsen.
If symptoms worsen, if fever persists for more than 3 days or pain for more than 5 days in adults, consult a doctor.
For oral administration.
Administration method with the syringe
In patients with stomach upset, it is recommended to administer the medication during meals.
If you take morePediatric Geloprofenthan you should
If you accidentally take or administer a dose of ibuprofen higher than recommended, consult your doctor or pharmacist immediately or call the toxicology information service, phone 91 562 04 20, indicating the medication and the amount used. It is recommended to take the package and the prospectus of the medication to the healthcare professional.
If you have taken more Pediatric Geloprofen than you should, or if a child has accidentally ingested the medication, consult immediately with a doctor or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
Symptoms of overdose include nausea, vomiting, abdominal pain, (which can contain bloody stools), headache, ringing in the ears, confusion, and involuntary eye movement or, more rarely, diarrhea. At high doses, dizziness, blurred vision, low blood pressure, excitement, disorientation, coma, hyperkalemia (elevated sodium levels in the blood), increased prothrombin time/INR, acute kidney failure, liver damage, respiratory depression, cyanosis, and exacerbation of asthma in asthmatics, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, chills, and breathing difficulties.
If you forget to take or give your childPediatric Geloprofen
Do not take or administer a double dose to make up for forgotten doses. If you forget to take or administer a dose, do so as soon as you remember and then take the next dose according to the previously indicated administration interval.
If you stop treatment withPediatric Geloprofen
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause adverse effects, although not everyone will experience them.
The incidence of adverse effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
The frequencies shown below refer to the short-term use of maximum daily doses of up to 1200 mg of oral ibuprofen:
Common Adverse Effects(may affect up to 1 in 10 patients)
Uncommon Adverse Effects(may affect up to 1 in 100 patients)
Rare Adverse Effects(may affect up to 1 in 1,000 people)
Very Rare Adverse Effects(may affect up to 1 in 10,000 people)
Frequency Not Known(cannot be estimated from available data)
If any of the following adverse effects occur, discontinue treatment and consult your doctor immediately:
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines, ww.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Once the package is opened, store below 30°C for a maximum of 6 months.
Do not use this medication after the expiration date that appears on the package after "CAD". The expiration date is the last day of the month indicated.
Medications should not be thrown away through the sewers or in the trash. Deposit the packages and medications you no longer need in the SIGRE Point of the pharmacy. Ask your pharmacist how to dispose of the packages and medications you no longer need. This way, you will help protect the environment.
Composition of Pediatric Geloprofen
Product Appearance and Package Contents
Pediatric Geloprofen is a viscous oral suspension, white or almost white in color, and with a strawberry flavor. It is presented in 150 ml PET containers, with a child safety cap.
It contains a 5 ml graduated syringe.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Ferrer Internacional, S.A.
Gran Vía Carlos III, 94
08028, Barcelona (Spain)
Manufacturer
DELPHARM BLADEL BV
Industrieweg 1
5531 AD Bladel
Netherlands
or
ZINEREO PHARMA, S.L.U.
A Relva - Torneiros, s/n, O Porriño,
36410 Pontevedra
Spain
or
FARMALIDER, S.A.
c/ Aragoneses 2- Polígono Industrial Alcobendas
28108- Alcobendas
Madrid
Spain
Or
FARMASIERRA MANUFACTURING S.L
Ctra de Irun Km 26,200
28700 (San Sebastian de los Reyes)
Madrid
Spain
Or
EDEFARM S.L.
Polígono Industrial Enchilagar del Rullo, 117
Villamarchante, Valencia, 46191, Spain
Date of the last revision of this prospectus: November 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)http://www.aemps.gob.es